Cryoablation Without Excision for Early-Stage Breast Cancer: ICE3 Trial 5-Year Follow-Up on Ipsilateral Breast Tumor Recurrence.

RE, Fine; RC, Gilmore; KR, Tomkovich; JR, Dietz; MP, Berry; LE, Hernandez; KS, Columbus; SA, Seedman; CS, Fisher; LK, Han; ER, Manahan; RD, Hicks; RP, Vaidya; LD, Curcio; AB, Sevrukov; AS, Kenler; B, Taback; M, Chen; ME, Miller; L, Gold; BV, Anglin; HD, Aoun; RM, Simmons; SM, Feldman; SK, Boolbol

doi:10.1245/s10434-024-16181-0

Public

Cryoablation Without Excision for Early-Stage Breast Cancer: ICE3 Trial 5-Year Follow-Up on Ipsilateral Breast Tumor Recurrence.

Shared by NobleBlocks on Sep 16, 2024 • 12:00 AM UTC

Authors:

Fine RE

Gilmore RC

Tomkovich KR

Abstract

<h4>Background</h4>The ICE3 trial evaluated the safety and efficacy of cryoablation in women aged ≥60 years with low-risk, early-stage breast cancers, aiming to provide a non-operative treatment option and avoid potential surgical risks. This study presents 5-year follow-up trial results.<h4>Methods...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!